Laquinimod reduces astrocytic NFκB activation in vitro and in vivo

被引：0
|
作者：
Kramann, Nadine [1 ]
Pfoertner, Ramona [1 ]
Brueck, Wolfgang [1 ]
Wegner, Christiane [1 ]
机构：
[1] Univ Med Ctr, Dept Neuropathol, Gottingen, Germany
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2012年 / 253卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [1] LAQUINIMOD REDUCES ASTROCYTIC BUT NOT MICROGLIAL NFKB ACTIVATION IN VITRO AND IN VIVO
    Kramann, N.
    Pfoertner, R.
    Hanisch, U. -K.
    Hagemeier, K.
    Kuhlmann, T.
    Brueck, W.
    Wegner, C.
    GLIA, 2013, 61 : S62 - S62
  • [2] Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
    Brueck, Wolfgang
    Pfoertner, Ramona
    Trinh Pham
    Zhang, Jingya
    Hayardeny, Liat
    Piryatinsky, Victor
    Hanisch, Uwe-Karsten
    Regen, Tommy
    van Rossum, Denise
    Brakelmann, Lars
    Hagemeier, Karin
    Kuhlmann, Tanja
    Stadelmann, Christine
    John, Gareth R.
    Kramann, Nadine
    Wegner, Christiane
    ACTA NEUROPATHOLOGICA, 2012, 124 (03) : 411 - 424
  • [3] Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
    Wolfgang Brück
    Ramona Pförtner
    Trinh Pham
    Jingya Zhang
    Liat Hayardeny
    Victor Piryatinsky
    Uwe-Karsten Hanisch
    Tommy Regen
    Denise van Rossum
    Lars Brakelmann
    Karin Hagemeier
    Tanja Kuhlmann
    Christine Stadelmann
    Gareth R. John
    Nadine Kramann
    Christiane Wegner
    Acta Neuropathologica, 2012, 124 : 411 - 424
  • [4] Laquinimod reduces neuronal caspase-6 activation and axonal degeneration in vitro
    Ehrnhoefer, D. E.
    Tsang, M. Y.
    Qiu, X.
    Hayden, M. R.
    MOVEMENT DISORDERS, 2014, 29 : S307 - S308
  • [5] LAQUINIMOD REDUCES NEURONAL CASPASE-6 ACTIVATION AND AXONAL DEGENERATION IN VITRO
    Ladha, S.
    Ehrnhoefer, D. E.
    Tsang, M.
    Qiu, X.
    Hayden, M. R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A96 - A97
  • [6] Laquinimod, an Immunomodulator that Reduces Microglial and Astrocytic Inflammation, as Treatment for Huntington Disease.
    Brueck, W.
    John, G.
    Zamvil, S. S.
    Yong, V. W.
    Pouladi, M.
    Loupe, P.
    Papapetropoulos, S.
    Hayardeny, L.
    NEUROTHERAPEUTICS, 2016, 13 (01) : 247 - 247
  • [7] Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo
    Marino, Silvia
    Bishop, Ryan T.
    Carrasco, Giovana
    Logan, John G.
    Li, Boya
    Idris, Aymen I.
    CALCIFIED TISSUE INTERNATIONAL, 2019, 105 (02) : 193 - 204
  • [8] Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo
    Silvia Marino
    Ryan T. Bishop
    Giovana Carrasco
    John G. Logan
    Boya Li
    Aymen I. Idris
    Calcified Tissue International, 2019, 105 : 193 - 204
  • [9] Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
    Mishra, Manoj Kumar
    Wang, Janet
    Keough, Michael B.
    Fan, Yan
    Silva, Claudia
    Sloka, Scott
    Hayardeny, Liat
    Brueck, Wolfgang
    Yong, V. Wee
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (06): : 409 - 422
  • [10] Inhibition of NF-κB activation in vitro and in vivo:: Role of 26S proteasome
    Grisham, MB
    Palombella, VJ
    Elliott, PJ
    Conner, EM
    Brand, S
    Wong, HL
    Pien, C
    Mazzola, LM
    Destree, A
    Parent, L
    Adams, J
    OXIDANTS AND ANTIOXIDANTS, PT B, 1999, 300 : 345 - 363
12345